DPD, DPYD, Fluoropyrimidines, DPD deficiency, Plasma uracil, Neutropenia, 30-day mortality, Fluoropyrimidine-related toxicity, Pretreatment DPD testing
suPAR, plasminogen activation system, pancreatic cancer, prognostic biomarker